EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Bioorthogonal Metabolic Labeling of the Virulence Factor Phenolic Glycolipid in Mycobacteria

Lindsay E Guzmán, C J Cambier, Tan-Yun Cheng, Kubra F Naqvi iD, Michael U Shiloh, D Branch Moody, Carolyn R Bertozzi iD

ACS Chemical Biology · 2024

DOI: 10.1021/acschembio.3c00724 ↗

At a glance

Journal article in ACS Chemical Biology, 2024. Written by Lindsay E Guzmán and 6 co-authors. Institution: Stanford Sarafan ChEM-H, Stanford University, Stanford, California 94305, United States. Major MEDLINE topics: Mycobacterium tuberculosis, Mycobacterium marinum. Cited 12 times so far (Crossref); 49 references. The full text is freely available (open access, CC BY 4.0). Funded by: NIAID NIH HHS, NIH HHS, Welch Foundation.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Surface lipids on pathogenic mycobacteria modulate infection outcomes by regulating host immune responses. Phenolic glycolipid (PGL) is a host-modulating surface lipid that varies among clinical Mycobacterium tuberculosis strains. PGL is also found in Mycobacterium marinum, where it promotes infection of zebrafish through effects on the innate immune system. Given the important role this lipid plays in the host-pathogen relationship, tools for profiling its abundance, spatial distribution, and dynamics are needed. Here, we report a strategy for imaging PGL in live mycobacteria using bioorthogonal metabolic labeling. We functionalized the PGL precursor p-hydroxybenzoic acid (pHB) with an azide group (3-azido pHB). When fed to mycobacteria, 3-azido pHB was incorporated into the cell surface, which could then be visualized via the bioorthogonal conjugation of a fluorescent probe. We confirmed that 3-azido pHB incorporates into PGL using mass spectrometry methods and demonstrated selectivity for PGL-producing M. marinum and M. tuberculosis strains. Finally, we applied this metabolic labeling strategy to study the dynamics of PGL within the mycobacterial membrane. This new tool enables visualization of PGL that may facilitate studies of mycobacterial pathogenesis.

Subjects

MeSH terms (MEDLINE)

Mycobacterium tuberculosisMycobacterium marinumAnimalsGlycolipidsVirulence FactorsZebrafish

Substances

GlycolipidsVirulence Factors

Authors and institutions

  • Stanford Sarafan ChEM-H, Stanford University, Stanford, California 94305, United States.
  • Department of Chemistry, Stanford University, Stanford, California 94305, United States.
  • Brigham and Women's Hospital, Division of Rheumatology, Inflammation and Immunity, Harvard Medical School, Boston, Massachusetts 02115, United States.
  • Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas 75390, United States.
  • Department of Microbiology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, United States.

ORCID profiles: Kubra F Naqvi, Carolyn R Bertozzi

Funding

  • NIAID NIH HHS
  • NIH HHS
  • Welch Foundation
  • Damon Runyon Cancer Research Foundation
  • National Institute of Allergy and Infectious Diseases
  • Burroughs Wellcome Fund

Cite

APA

Guzmán, L. E., Cambier, C. J., Cheng, T. Y., Naqvi, K. F., Shiloh, M. U., Moody, D. B., & Bertozzi, C. R. (2024). Bioorthogonal Metabolic Labeling of the Virulence Factor Phenolic Glycolipid in Mycobacteria. ACS Chemical Biology. https://doi.org/10.1021/acschembio.3c00724

Vancouver

Guzmán LE, Cambier CJ, Cheng TY, Naqvi KF, Shiloh MU, Moody DB, et al. Bioorthogonal Metabolic Labeling of the Virulence Factor Phenolic Glycolipid in Mycobacteria. ACS Chemical Biology. 2024. doi:10.1021/acschembio.3c00724

BibTeX
@article{Guzmn2024,
  author = {Guzmán, Lindsay E and Cambier, C J and Cheng, Tan-Yun and Naqvi, Kubra F and Shiloh, Michael U and Moody, D Branch and Bertozzi, Carolyn R},
  title = {Bioorthogonal Metabolic Labeling of the Virulence Factor Phenolic Glycolipid in Mycobacteria},
  journal = {ACS Chemical Biology},
  year = {2024},
  doi = {10.1021/acschembio.3c00724}
}
Start for free →